Anticipated Effects of Decreasing Federal Support for Syringe Exchange Programs

Overview

This report examines the potential impact of reduced federal funding for syringe exchange programs (SSPs) on overdose mortality among persons who inject drugs in the U.S. Using a microsimulation model, the study explores various scenarios of funding disruption and its implications for public health.

Background

The opioid epidemic has led to significant morbidity and mortality in the U.S., necessitating effective harm reduction strategies. Syringe service programs (SSPs) play a critical role in reducing overdose risks and infectious disease transmission among people who inject drugs. However, these programs face funding challenges that could be exacerbated by recent federal policy changes.

Data Highlights

The study utilized a validated microsimulation model to assess the outcomes of federal funding reductions for SSPs over a five-year period, comparing scenarios of low and high service disruptions.

Key Findings

• SSPs are underfunded, with only 41 syringes distributed per person who injects drugs annually in North America.
• Elimination of federal funding could lead to significant service reductions, particularly in rural areas.
• Simulation modeling indicated that even a modest reduction in SSP services could adversely affect mortality rates among persons who inject drugs.
• Historical context shows that federal funding bans have previously led to increased HIV outbreaks among this population.
• Current federal support for SSPs has been crucial in maintaining access to harm reduction services.

Clinical Implications

Healthcare providers should be aware of the potential consequences of reduced federal funding for SSPs, as it may limit access to critical harm reduction services. Continued advocacy for funding and support of SSPs is essential to mitigate the risks of overdose and infectious diseases.

Conclusion

The anticipated effects of decreased federal support for SSPs could significantly impact public health outcomes related to the opioid epidemic. Maintaining robust funding for these programs is vital to ensure continued access to harm reduction services.

Related Resources & Content

1. Associated Press Health, AP News, 2023 -- Indiana’s needle exchange programs are on the chopping block
2. Associated Press Health, AP News, 2023 -- Indiana community fights to keep needle exchange going after Trump order
3. JAMA Network Open, JAMA Network, 2023 -- Driving Time, Distance, and Cost to Access Syringe Services Programs in the US
4. CDC Newsroom, CDC, 2025 -- Statement from CDC’s National Center for Injury Prevention and Control on Provisional 2024 Overdose Death Data
5. World Health Organization, WHO, 2026 -- Needle and syringe programmes for people who inject drugs: operational guide
6. Frontiers in Psychiatry — Case Report: Reintroduction of winged infusion sets to needle syringe programs - advancing equity in harm reduction
7. CDC Newsroom Statement on Overdose Death Data
8. WHO Operational Guide on Needle and Syringe Programmes
9. Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis - PMC